Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, ...

HbA1c tests provide an average indication of blood sugar control over the past 2-3 months, which helps in managing diabetes ...

For people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally ...

The daily tablet can help reduce pain and inflammation caused by the chronic and often debilitating condition.

The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed ...

Now approved in over 20 cancer types and used in earlier lines of therapy, immune checkpoint inhibitors (ICIs) have ...